{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T14:46:27Z","timestamp":1785681987671,"version":"3.56.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:p>Blast evaluation in patients with acute monocytic leukemias (AMoL) is notoriously difficult due to the lack of reliable surface markers and cytologic subtleties on the aspirate smears. While blasts of most nonmonocytic acute leukemias express CD34, available immunohistochemical antibodies to monocytic blasts also mark normal background mature monocytes. We searched for a potential biomarker candidate by surveying specific gene expression profiles of monocyte progenitors. Our investigations led us to IRF8, which is a lineage-specific transcription factor critical for the production of monocytic and dendritic cell progenitors. In this study, we tested and validated a monoclonal antibody to IRF8 as a novel immunohistochemical stain for trephine core biopsies of human bone marrow. We assessed the expression of IRF8 in 90 cases of AMoL, including posttherapy staging bone marrows, 23 cases of chronic myelomonocytic leukemia, 26 cases of other acute myeloid leukemia subtypes, and 18 normal control marrows. In AMoL, there was high correlation of IRF8-positive cells to aspirate blast count (<jats:italic toggle=\"yes\">R<\/jats:italic>=0.95). Comparison of IRF8 staining to aspirate blast percentage in chronic myelomonocytic leukemia also showed good correlation (<jats:italic toggle=\"yes\">R<\/jats:italic>=0.86). In contrast, IRF8-positive cells did not correlate with blast count in other subtypes of acute myeloid leukemia (<jats:italic toggle=\"yes\">R<\/jats:italic>=0.56) and staining was &lt;5% in all normal control marrows, even those with reactive monocytosis. We found that IRF8 was also weakly reactive in B cells and hematogones, with the latter accounting for rare cases of discrepancies. When IRF8 was used to categorize cases as AMoL, positive for residual leukemia or negative, the sensitivity was 98%, specificity was 82%, positive predictive value was 86%, and negative predictive value was 98%. These results demonstrate that IRF8 may serve as a clinically useful immunostain to diagnose and track AMoLs on bone marrow core biopsies. This can be particularly impactful in the setting of poor aspiration and focal blast increase. In the era of new targeted therapies that have been reported to induce monocytic outgrowths of leukemia, a marker for malignant monoblasts may prove even more critical.<\/jats:p>","DOI":"10.1097\/pas.0000000000001765","type":"journal-article","created":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T06:01:43Z","timestamp":1624687303000},"page":"1391-1398","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":30,"title":["IRF8 is a Reliable Monoblast Marker for Acute Monocytic Leukemias"],"prefix":"10.1097","volume":"45","author":[{"given":"Samuel G.","family":"Katz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susmitha","family":"Edappallath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina L.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,6,24]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1182\/blood.V92.11.4325","article-title":"Most acute myeloid leukemia progenitor cells with long-term proliferative ability in vitro and in vivo have the phenotype CD34(+)\/CD71(-)\/HLA-DR","volume":"92","author":"Blair","year":"1998","journal-title":"Blood"},{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3324\/haematol.2008.005421","article-title":"Morphological evaluation of monocytes and their precursors","volume":"94","author":"Goasguen","year":"2009","journal-title":"Haematologica"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1056\/NEJMe1802610","article-title":"Clonal hematopoiesis after induction chemotherapy for acute myeloid leukemia","volume":"378","author":"Steensma","year":"2018","journal-title":"N Engl J Med"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/ijlh.12776","article-title":"How I investigate monocytosis","volume":"40","author":"Lynch","year":"2018","journal-title":"Int J Lab Hematol"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1084\/jem.169.5.1721","article-title":"Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties","volume":"169","author":"Andrews","year":"1989","journal-title":"J Exp Med"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1182\/blood.V98.12.3249","article-title":"Diagnostic and clinical relevance of the number of circulating CD34(+) cells in myelofibrosis with myeloid metaplasia","volume":"98","author":"Barosi","year":"2001","journal-title":"Blood"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.immuni.2017.04.019","article-title":"Identification of a human clonogenic progenitor with strict monocyte differentiation potential: a counterpart of mouse cMoPs","volume":"46","author":"Kawamura","year":"2017","journal-title":"Immunity"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1158\/2159-8290.CD-19-0710","article-title":"Monocytic subclones confer resistance to venetoclax-based therapy in patients with acute myeloid leukemia","volume":"10","author":"Pei","year":"2020","journal-title":"Cancer Discov"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1365-2559.2012.04175.x","article-title":"The value of immunohistochemistry for CD14, CD123, CD33, myeloperoxidase and CD68R in the diagnosis of acute and chronic myelomonocytic leukaemias","volume":"60","author":"Rollins-Raval","year":"2012","journal-title":"Histopathology"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/sj.leu.2404242","article-title":"Immunophenotypic identification of acute myeloid leukemia with monocytic differentiation","volume":"20","author":"Xu","year":"2006","journal-title":"Leukemia"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1182\/blood-2012-06-437863","article-title":"Essential role of the IRF8-KLF4 transcription factor cascade in murine monocyte differentiation","volume":"121","author":"Kurotaki","year":"2013","journal-title":"Blood"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1084\/jem.20021263","article-title":"ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cells","volume":"196","author":"Schiavoni","year":"2002","journal-title":"J Exp Med"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.4049\/jimmunol.174.5.2573","article-title":"IFN regulatory factor-4 and -8 govern dendritic cell subset development and their functional diversity","volume":"174","author":"Tamura","year":"2005","journal-title":"J Immunol"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev.immunol.26.021607.090400","article-title":"The IRF family transcription factors in immunity and oncogenesis","volume":"26","author":"Tamura","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0092-8674(00)81348-3","article-title":"Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene","volume":"87","author":"Holtschke","year":"1996","journal-title":"Cell"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1100066","article-title":"IRF8 mutations and human dendritic-cell immunodeficiency","volume":"365","author":"Hambleton","year":"2011","journal-title":"N Engl J Med"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s12308-020-00394-9","article-title":"Enumeration of CD34+ blasts by immunohistochemistry in bone marrow biopsies from MDS patients may have significant impact on final WHO classification","volume":"13","author":"Saft","year":"2020","journal-title":"J Hematopathol"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/cncr.30361","article-title":"Persistence of minimal residual disease assessed by multiparameter flow cytometry is highly prognostic in younger patients with acute myeloid leukemia","volume":"123","author":"Ravandi","year":"2017","journal-title":"Cancer"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.blre.2016.09.006","article-title":"Monitoring minimal residual disease in acute leukemia: technical challenges and interpretive complexities","volume":"31","author":"Chen","year":"2017","journal-title":"Blood Rev"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1182\/blood-2012-11-468348","article-title":"MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial","volume":"121","author":"Zhu","year":"2013","journal-title":"Blood"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa1716863","article-title":"Molecular minimal residual disease in acute myeloid leukemia","volume":"378","author":"Jongen-Lavrencic","year":"2018","journal-title":"N Engl J Med"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1309\/FY0UMAMM91VPMR2W","article-title":"Incidence, sensitivity, and specificity of leukemia-associated phenotypes in acute myeloid leukemia using specific five-color multiparameter flow cytometry","volume":"129","author":"Al-Mawali","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1200\/JCO.2011.41.5323","article-title":"Comparative analysis of different approaches to measure treatment response in acute myeloid leukemia","volume":"30","author":"Inaba","year":"2012","journal-title":"J Clin Oncol"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1182\/bloodadvances.2018020222","article-title":"Clinical consequences of clonal hematopoiesis of indeterminate potential","volume":"2","author":"Steensma","year":"2018","journal-title":"Blood Adv"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/1878-0261.12727","article-title":"Clinical significance of clonal hematopoiesis in the interpretation of blood liquid biopsy","volume":"14","author":"Chan","year":"2020","journal-title":"Mol Oncol"},{"key":"R29-20250608","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/ajh.25104","article-title":"Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management","volume":"93","author":"Patnaik","year":"2018","journal-title":"Am J Hematol"},{"key":"R30-20250608","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1182\/blood-2008-01-129049","article-title":"IRF8 regulates B-cell lineage specification, commitment, and differentiation","volume":"112","author":"Wang","year":"2008","journal-title":"Blood"},{"key":"R31-20250608","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3324\/haematol.11051","article-title":"Chronic myelomonocytic leukemia in the light of the WHO proposals","volume":"92","author":"Germing","year":"2007","journal-title":"Haematologica"},{"key":"R32-20250608","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1182\/blood-2003-08-2970","article-title":"Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR\/ABL and down-regulates bcl-2","volume":"103","author":"Burchert","year":"2004","journal-title":"Blood"},{"key":"R33-20250608","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1084\/jem.190.3.411","article-title":"Regulation of apoptosis in myeloid cells by interferon consensus sequence-binding protein","volume":"190","author":"Gabriele","year":"1999","journal-title":"J Exp Med"},{"key":"R34-20250608","doi-asserted-by":"crossref","first-page":"19103","DOI":"10.1074\/jbc.M112.434530","article-title":"Deregulation of apoptotic factors Bcl-xL and Bax confers apoptotic resistance to myeloid-derived suppressor cells and contributes to their persistence in cancer","volume":"288","author":"Hu","year":"2013","journal-title":"J Biol Chem"},{"key":"R35-20250608","doi-asserted-by":"crossref","first-page":"4775","DOI":"10.4049\/jimmunol.179.7.4775","article-title":"IFN regulatory factor 8 mediates apoptosis in nonhemopoietic tumor cells via regulation of Fas expression","volume":"179","author":"Yang","year":"2007","journal-title":"J Immunol"},{"key":"R36-20250608","doi-asserted-by":"crossref","first-page":"4426","DOI":"10.4049\/jimmunol.1101034","article-title":"Cutting edge: IRF8 regulates Bax transcription in vivo in primary myeloid cells","volume":"187","author":"Yang","year":"2011","journal-title":"J Immunol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001765","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T21:05:12Z","timestamp":1749416712000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,24]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001765","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,24]]}}}